Overview
Tilray fiscal Q1 2026 net revenue rises 5% yr/yr to $209.5 mln
Net income for fiscal Q1 2026 was $1.5 mln, a turnaround from a net loss
Adjusted EBITDA for fiscal Q1 2026 increased 9% to $10.2 mln
Outlook
Tilray reiterates fiscal year 2026 adjusted EBITDA outlook of $62 mln to $72 mln
Result Drivers
OPERATIONAL EFFICIENCIES - Co attributes net income improvement to operational efficiencies and focus on profitability
CANADIAN CANNABIS GROWTH - Canadian adult-use cannabis gross revenue increased 12%, maintaining #1 position in revenue and expanding market share
INTERNATIONAL REVENUE - International cannabis revenue grew 10% yr/yr
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q1 Revenue |
| $209.50 mln |
|
Q1 EPS |
|
|
|
Q1 Adjusted Net Income |
| $3.90 mln |
|
Q1 Net Income |
| $1.51 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
Wall Street's median 12-month price target for Tilray Brands Inc is C$1.36, about 77.2% below its October 8 closing price of C$2.41
Press Release: ID:nGNE6NjhVB
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.